Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial Journal Article


Authors: Kindler, H. L.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; Reinacher-Schick, A. C.; Tortora, G.; Algul, H.; O'Reilly, E. M.; McGuinness, D.; Cui, K.; Schlienger, K.; Locker, G. Y.; Golan, T.
Article Title: Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 18
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-06-01
Language: English
ACCESSION: WOS:000489109800010
DOI: 10.1200/JCO.2019.37.18_suppl.LBA4
PROVIDER: wos
Notes: Meeting Abstract -- Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2019 -- Chicago, IL -- S -- Source: Wos
Altmetric Score